BMS-813160
- Generic Name
- BMS-813160
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H40N8O2
- CAS Number
- 1286279-29-5
- Unique Ingredient Identifier
- 83U7957287
- Background
BMS-813160 is under investigation in clinical trial NCT03496662 (BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)).
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath